These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19422312)

  • 1. Lung deposition of a liposomal cyclosporine A inhalation solution in patients after lung transplantation.
    Behr J; Zimmermann G; Baumgartner R; Leuchte H; Neurohr C; Brand P; Herpich C; Sommerer K; Seitz J; Menges G; Tillmanns S; Keller M;
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):121-30. PubMed ID: 19422312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung deposition and pharmacokinetics of nebulized cyclosporine in lung transplant patients.
    Corcoran TE; Niven R; Verret W; Dilly S; Johnson BA
    J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):178-84. PubMed ID: 23668548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers.
    Weers J; Metzheiser B; Taylor G; Warren S; Meers P; Perkins WR
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):131-8. PubMed ID: 19422313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosolized protein delivery in asthma: gamma camera analysis of regional deposition and perfusion.
    Sangwan S; Agosti JM; Bauer LA; Otulana BA; Morishige RJ; Cipolla DC; Blanchard JD; Smaldone GC
    J Aerosol Med; 2001; 14(2):185-95. PubMed ID: 11681650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical Trial of Inhaled Liposomal Cyclosporine Plus Standard-of-Care Versus Standard-of-Care Alone for Bronchiolitis Obliterans Syndrome After Lung Transplantation.
    Iacono A; Wijesinha M; Völp A; Korotun M; Terrin M
    Ann Transplant; 2024 May; 29():e942823. PubMed ID: 38741362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery and distribution of aerosolized cyclosporine in lung allograft recipients.
    O'Riordan TG; Iacono A; Keenan RJ; Duncan SR; Burckart GJ; Griffith BP; Smaldone GC
    Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):516-21. PubMed ID: 7842214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation.
    Neurohr C; Kneidinger N; Ghiani A; Monforte V; Knoop C; Jaksch P; Parmar J; Ussetti P; Sole A; Müller-Quernheim J; Kessler R; Wirtz H; Boerner G; Denk O; Prante Fernandes S; Behr J
    Am J Transplant; 2022 Jan; 22(1):222-229. PubMed ID: 34587371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-related reversal of acute lung rejection by aerosolized cyclosporine.
    Iacono AT; Smaldone GC; Keenan RJ; Diot P; Dauber JH; Zeevi A; Burckart GJ; Griffith BP
    Am J Respir Crit Care Med; 1997 May; 155(5):1690-8. PubMed ID: 9154878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of liposomal aerosolized cyclosporine A for pulmonary immunosuppression.
    Letsou GV; Safi HJ; Reardon MJ; Ergenoglu M; Li Z; Klonaris CN; Baldwin JC; Gilbert BE; Waldrep JC
    Ann Thorac Surg; 1999 Dec; 68(6):2044-8. PubMed ID: 10616974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between cyclosporine concentrations at 2 hours post-dose and trough levels with functional outcomes in de novo lung transplant recipients.
    Maziers N; Bulpa P; Jamart J; Delaunois L; Eucher P; Evrard P
    Transplant Proc; 2012 Nov; 44(9):2880-4. PubMed ID: 23146546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biokinetics of Aerosolized Liposomal Ciclosporin A in Human Lung Cells In Vitro Using an Air-Liquid Cell Interface Exposure System.
    Schmid O; Jud C; Umehara Y; Mueller D; Bucholski A; Gruber F; Denk O; Egle R; Petri-Fink A; Rothen-Rutishauser B
    J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):411-424. PubMed ID: 28683218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance of volunteers to cyclosporine A-dilauroylphosphatidylcholine liposome aerosol.
    Gilbert BE; Knight C; Alvarez FG; Waldrep C; Rodarte JR; Knight V; Eschenbacher WL
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1789-93. PubMed ID: 9412556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of the effect of cyclodextrin complexation on pulmonary deposition of a peptide, cyclosporin A.
    Matilainen L; Järvinen K; Toropainen T; Näsi E; Auriola S; Järvinen T; Jarho P
    Int J Pharm; 2006 Aug; 318(1-2):41-8. PubMed ID: 16624508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion from cyclosporine to tacrolimus stabilizes the course of lung function in lung transplant recipients with bronchiolitis obliterans syndrome.
    Borro JM; Bravo C; Solé A; Usetti P; Zurbano F; Lama R; De la Torre M; Román A; Pastor A; Laporta R; Cifrián JM; Santos F
    Transplant Proc; 2007 Sep; 39(7):2416-9. PubMed ID: 17889206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative studies of airway deposition of 99mTc-DTPA aerosol particles among 4 different nebulizers by pulmonary scintillation method].
    Yamaguchi H; Shiigai N; Mitsubayashi K; Oosika E; Okada F; Mitsubayashi T; Sasaki N; Iseya O; Miyamae T; Suzuki I; Akasaka T
    Arerugi; 1997 Oct; 46(10):1052-7. PubMed ID: 9404093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenges of quantitative measurement of lung deposition using 99mTc-DTPA from delivery systems with very different delivery times.
    Coates AL; Green M; Leung K; Louca E; Tservistas M; Chan J; Ribeiro N; Charron M
    J Aerosol Med; 2007; 20(3):320-30. PubMed ID: 17894538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosolized tacrolimus: a case report in a lung transplant recipient.
    Hayes D; Zwischenberger JB; Mansour HM
    Transplant Proc; 2010 Nov; 42(9):3876-9. PubMed ID: 21094875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive expiratory pressure changes aerosol distribution in patients with cystic fibrosis.
    Laube BL; Geller DE; Lin TC; Dalby RN; Diener-West M; Zeitlin PL
    Respir Care; 2005 Nov; 50(11):1438-44. PubMed ID: 16253150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of lung function and deposition of aerosolized bronchodilators carried by heliox associated with positive expiratory pressure in stable asthmatics: a randomized clinical trial.
    Alcoforado L; Brandão S; Rattes C; Brandão D; Lima V; Ferreira Lima G; Fink JB; Dornelas de Andrade A
    Respir Med; 2013 Aug; 107(8):1178-85. PubMed ID: 23664767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.